IONS FY2025 SEC EDGAR DEF 14A #83 of 168 in industry

Ionis Pharmaceuticals Inc CEO pay ratio

The CEO earned $13.4M in FY2025 against median worker pay of $304,680 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
CA
Filing date
2026-04-23
Industry
Chemicals & Pharmaceuticals
Industry rank
#83/168

Data updated August 2026

Subscribe to Ionis Pharmaceuticals Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
44:1
Below Average (Scale: 0–1000:1)
CEO pay
$13.4M
Median worker
$304,680

Answer first

Ionis Pharmaceuticals Inc's FY2025 CEO total of $13.4M ranks #365 of 1,423 complete filings; its 44:1 pay ratio ranks #1028. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $304,680. Industry placement uses the FY2025 SIC-28 peer cohort (# 83 of 168, 51st percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#365
$13.4M of 1,423 FY2025
Ratio rank
#1028
44:1 of 1,423
Industry pct
51st
above the industry median pay ratio

How Ionis Pharmaceuticals Inc ranks nationally

Ionis Pharmaceuticals Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$13,350,777 Top 26% higher than 74% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). This entry sits in this band. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Ionis Pharmaceuticals Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($13.4M) against pay ratio (44:1) for Ionis Pharmaceuticals Inc (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both04015316.68030633.212045949.816061266.441.8:142.9:144:145.1:146.2:1CEO total payPay ratio (CEO : median worker)Ionis Pharmaceuticals Inc, CEO total pay: 13350777 · Pay ratio (CEO : median worker): 44:1Ionis Pharmaceuticals IncOlaplex Holdings, Inc., CEO total pay: 149243 · Pay ratio (CEO : median worker): 44:1Olaplex Holdings, Inc.Orion S.A., CEO total pay: 3488971 · Pay ratio (CEO : median worker): 45:1Orion S.A.Corcept Therapeutics Inc, CEO total pay: 15303551 · Pay ratio (CEO : median worker): 46:1Corcept Therapeutics IncRegeneron Pharmaceuticals, Inc., CEO total pay: 7313796 · Pay ratio (CEO : median worker): 42:1Regeneron Pharmaceuticals, Inc.
Ionis Pharmaceuticals Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Ionis Pharmaceuticals Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Ionis Pharmaceuticals Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
44:1
FY2025
vs prior FY
-26:1
from FY2024 70:1
CEO $ YoY
-13%
$13.4M latest
Filings shown
5
FY2021–2025
Ionis Pharmaceuticals Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $13.3M - $226,222 58:1 -
2022 $7.3M -45% $183,487 40:1 -18:1
2023 $12.5M +71% $318,112 39:1 -1:1
2024 $15.4M +23% $220,397 70:1 +31:1
2025 $13.4M -13% $304,680 44:1 -26:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 874015, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
44:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$13.4M
Companies in Industry
168
vs. Industry Median
Above
#83 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Ionis Pharmaceuticals Inc: MODEST · HEAVY pay ratio

Ionis Pharmaceuticals Inc's FY2025 CEO total $13.4M ranks #365 of 1,423 complete filings (higher third by dollars). the CEO earned 44× the median employee ($304,680) in FY2025.

Median employee $304,680 (ELITE-MED); MODEST · HEAVY stamps put about 44 median-wage years per CEO year.

CEO Total Pay

$13.4M

FY2025 Summary Compensation, above median

Pay Ratio

44:1

Below typical

Ionis Pharmaceuticals Inc in the higher-dollar third

Ionis Pharmaceuticals Inc's FY2025 CEO total $13.4M ranks #365 of 1,423 complete filings (higher third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Ionis Pharmaceuticals Inc's $13.4M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #365 and ratio rank #1028 split - treat 44:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$13.4M
Median Employee Pay
$304,680
Pay Ratio
44:1
Filing Date
2026-04-23

Company Info

Ticker
IONS
CIK
874015
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
CA
View SEC filings →
SEC EDGAR DEF 14A for CIK 874015, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Ionis Pharmaceuticals Inc's FY2025 CEO total $13.4M ranks #365 of 1,423 complete filings (higher third by dollars).

Read with Ionis Pharmaceuticals Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

Red Rock Resorts, Inc. · HEAVY

ABS(ceo_total_comp) peer at $13.3M (Δ $2K lighter vs Ionis Pharmaceuticals Inc); STEEP · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Green Brick Partners, Inc. · HEAVY

ABS(ceo_total_comp) peer at $13.4M (Δ $51K heavier vs Ionis Pharmaceuticals Inc); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Reliance, Inc. · HEAVY

ABS(ceo_total_comp) peer at $13.4M (Δ $57K heavier vs Ionis Pharmaceuticals Inc); STEEP · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
ManpowerGroup Inc. · HEAVY

ABS(ceo_total_comp) peer at $13.3M (Δ $85K lighter vs Ionis Pharmaceuticals Inc); EXTREME · LOW-MED vs this page's MODEST · HEAVY · ELITE-MED.
Luxfer Holdings PLC (SIC 28 pole)

Luxfer Holdings PLC stamps MODEST · UNFILED nearest in-SIC by ABS(pay_ratio) to Ionis Pharmaceuticals Inc's MODEST filing.
National dual ranks · #365/#1028

Ionis Pharmaceuticals Inc's FY2025 package sits #365 by CEO dollars and #1028 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Ionis Pharmaceuticals Inc's MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Ionis Pharmaceuticals Inc (CIK 874015), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.